Pathology, Carcinoma, Serous fluid, Serous carcinoma and Cancer are his primary areas of study. His work on Carcinoma in situ as part of general Pathology research is frequently linked to Pseudomyxoma peritonei, bridging the gap between disciplines. His Carcinoma research incorporates elements of Hyperplasia and Atypia.
His Serous fluid study integrates concerns from other disciplines, such as Ovarian carcinoma, Cystadenocarcinoma, Micropapillary Serous Carcinoma, Fallopian tube and Endometrial hyperplasia. The various areas that Robert J. Kurman examines in his Serous carcinoma study include Cancer research and KRAS. His Cancer research is multidisciplinary, incorporating perspectives in Guideline, Gynecology and Oncology.
His scientific interests lie mostly in Pathology, Serous fluid, Carcinoma, Serous carcinoma and Internal medicine. His study on Pathology also encompasses disciplines like
His Carcinoma research incorporates themes from Endometrium, Radiology and Hyperplasia. Robert J. Kurman has included themes like Carcinogenesis, Tumor progression, Serous Cystadenoma and Clear cell carcinoma in his Serous carcinoma study. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Gynecology and Oncology.
Robert J. Kurman focuses on Pathology, Serous fluid, Serous carcinoma, Carcinoma and Ovarian cancer. Robert J. Kurman studies Pathology, namely Immunohistochemistry. His Serous fluid study integrates concerns from other disciplines, such as Serous Tubal Intraepithelial Carcinoma, Cancer research, Gynecology and Cystadenocarcinoma.
He works mostly in the field of Serous carcinoma, limiting it down to topics relating to Serous Cystadenoma and, in certain cases, Serous tumour, as a part of the same area of interest. Robert J. Kurman works mostly in the field of Carcinoma, limiting it down to concerns involving Adenocarcinoma and, occasionally, Endometrium. In his study, Carcinosarcoma, Risk factor and Young adult is strongly linked to Oncology, which falls under the umbrella field of Ovarian cancer.
Serous fluid, Pathology, Fallopian tube, Ovarian cancer and Serous carcinoma are his primary areas of study. His Serous fluid study combines topics from a wide range of disciplines, such as Cancer research, Serous Tubal Intraepithelial Carcinoma, Ovarian carcinoma, Carcinoma and Cystadenocarcinoma. His Carcinoma study incorporates themes from Uterine Neoplasm, Somatic cell and Adenocarcinoma.
The study incorporates disciplines such as Telomere, Gestational trophoblastic disease and Ovary in addition to Pathology. His Fallopian tube study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
F X Bosch;M M Manos;N Muñoz;M Sherman.
Journal of the National Cancer Institute (1995)
The 2001 Bethesda System: terminology for reporting results of cervical cytology.
Diane Solomon;Diane Davey;Robert Kurman;Marianne Prey.
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)
WHO classification of tumours of female reproductive organs
Robert J. Kurman;Maria Luisa Carcangiu;C. Simon Herrington;Robert H. Young.
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Robert J. Kurman;Ie Ming Shih.
The American Journal of Surgical Pathology (2010)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
Mark H. Schiffman;Heidi M. Bauer;Robert N. Hoover;Andrew G. Glass.
Journal of the National Cancer Institute (1993)
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
C.Paul Morrow;Brian N. Bundy;Robert J. Kurman;William T. Creasman.
Gynecologic Oncology (1991)
Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis
Ie Ming Shih;Robert J. Kurman.
American Journal of Pathology (2004)
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.
A T Lorincz;R Reid;A B Jenson;M D Greenberg.
Obstetrics & Gynecology (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: